Status:
COMPLETED
Sublingual Misoprostol & Isoflurane During Caesarean Section
Lead Sponsor:
Mansoura University
Conditions:
Pregnancy
Cesarean Delivery
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
Misoprostol would reduce the uterine bleeding after caesarean delivery, without harmful effects on either mother or baby. The investigators postulated that the use of sublingual misoprostol during iso...
Detailed Description
Volatile anaesthetics including sevoflurane, desflurane, and isoflurane are often used during general anaesthesia for caesarean delivery. The cost effectiveness of isoflurane anaesthesia1 for caesarea...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists class I and II
- parturients aged 18-35 years
- uncomplicated singleton pregnancies
- Gestational age \>= 36 weeks
- elective caesarean delivery
- refused regional anaesthesia
- requested general anaesthesia.
Exclusion
- allergy to prostaglandins
- bronchial asthma
- anaemia
- bleeding disorders
- cardiac diseases
- inflammatory bowel diseases
- multiple pregnancies
- preeclampsia
- placenta praevia
- abruptio placenta
- previous postpartum haemorrhage
- antepartum haemorrhage
- grand multiparity
- uterine fibroids
- intrauterine growth restriction
- fetal abnormality
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT01466530
Start Date
January 1 2006
End Date
September 1 2011
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
College of Medicine, Mansoura University
Al Mansurah, DK, Egypt, 050